These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24835980)

  • 1. Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD.
    McKinnell RM; Klein U; Linsell MS; Moran EJ; Nodwell MB; Pfeiffer JW; Thomas GR; Yu C; Jacobsen JR
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2871-6. PubMed ID: 24835980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multivalent approach to the discovery of long-acting β(2)-adrenoceptor agonists for the treatment of asthma and COPD.
    Jacobsen JR; Choi SK; Combs J; Fournier EJ; Klein U; Pfeiffer JW; Thomas GR; Yu C; Moran EJ
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1213-8. PubMed ID: 22178551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivalent design of long-acting β(2)-adrenoceptor agonists incorporating biarylamines.
    Jacobsen JR; Aggen JB; Church TJ; Klein U; Pfeiffer JW; Pulido-Rios TM; Thomas GR; Yu C; Moran EJ
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2625-30. PubMed ID: 24813741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonist.
    Arnold N; Beattie D; Bradley M; Brearley A; Brown L; Charlton SJ; Fairhurst RA; Farr D; Fozard J; Fullerton J; Gosling M; Hatto J; Janus D; Jones D; Jordan L; Lewis C; Maas J; McCarthy C; Mercer M; Oakman H; Press N; Profit R; Schuerch F; Sykes D; Taylor RJ; Trifilieff A; Tuffnell A
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4341-7. PubMed ID: 25065493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro pharmacology of GS-5759, a novel bifunctional phosphodiesterase 4 inhibitor and long acting β2-adrenoceptor agonist.
    Tannheimer SL; Sorensen EA; Cui ZH; Kim M; Patel L; Baker WR; Phillips GB; Wright CD; Salmon M
    J Pharmacol Exp Ther; 2014 Apr; 349(1):85-93. PubMed ID: 24513870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models.
    Aparici M; Gómez-Angelats M; Vilella D; Otal R; Carcasona C; Viñals M; Ramos I; Gavaldà A; De Alba J; Gras J; Cortijo J; Morcillo E; Puig C; Ryder H; Beleta J; Miralpeix M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):497-509. PubMed ID: 22588259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol.
    Aparici M; Gavaldà A; Ramos I; Carcasona C; Otal R; Fernández-Blanco JA; Montero JL; García VM; López R; De Alba J; Doe C; Puig C; Vilella D; Miralpeix M
    Eur J Pharmacol; 2016 Jan; 770():61-9. PubMed ID: 26656755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol.
    Beattie D; Beer D; Bradley ME; Bruce I; Charlton SJ; Cuenoud BM; Fairhurst RA; Farr D; Fozard JR; Janus D; Rosethorne EM; Sandham DA; Sykes DA; Trifilieff A; Turner KL; Wissler E
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6280-5. PubMed ID: 22932315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design-driven LO: the discovery of new ultra long acting dibasic β2-adrenoceptor agonists.
    Connolly S; Alcaraz L; Bailey A; Cadogan E; Christie J; Cook AR; Fisher AJ; Hill S; Humphries A; Ingall AH; Kane Z; Paine S; Pairaudeau G; Stocks MJ; Young A
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4612-6. PubMed ID: 21723724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action.
    Nicholls DJ; Jordan S; Cadogan E; Lawson M; Austin RP; Paine SW; Gardiner P; Bonnert R; Connolly S; Young A
    Pulm Pharmacol Ther; 2012 Aug; 25(4):293-302. PubMed ID: 22659538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of dual pharmacology β2-adrenoceptor agonists and PDE4 inhibitors.
    Huang L; Shan W; Zhou Q; Xie J; Lai K; Li X
    Bioorg Med Chem Lett; 2014 Jan; 24(1):249-53. PubMed ID: 24300734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual β2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD.
    Shan WJ; Huang L; Zhou Q; Jiang HL; Luo ZH; Lai KF; Li XS
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1523-6. PubMed ID: 22297114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β
    Rancati F; Linney ID; Rizzi A; Delcanale M; Knight CK; Schmidt W; Pastore F; Riccardi B; Mileo V; Carnini C; Cesari N; Blackaby WP; Patacchini R; Carzaniga L
    Bioorg Med Chem Lett; 2021 Jun; 41():127975. PubMed ID: 33753262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of indole-derived long acting beta2-adrenoceptor agonists for the treatment of asthma and COPD.
    Brown AD; Bunnage ME; Glossop PA; Holbrook M; Jones RD; Lane CA; Lewthwaite RA; Mantell S; Perros-Huguet C; Price DA; Webster R
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6188-91. PubMed ID: 17897826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of β2-agonists.
    Hizawa N
    Allergol Int; 2011 Sep; 60(3):239-46. PubMed ID: 21681016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra long-acting beta 2-agonists in development for asthma and chronic obstructive pulmonary disease.
    Cazzola M; Matera MG; Lötvall J
    Expert Opin Investig Drugs; 2005 Jul; 14(7):775-83. PubMed ID: 16022567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating hydantoin or uracil rings.
    Procopiou PA; Barrett VJ; Bevan NJ; Butchers PR; Conroy R; Emmons A; Ford AJ; Jeulin S; Looker BE; Lunniss GE; Morrison VS; Mutch PJ; Perciaccante R; Ruston M; Smith CE; Somers G
    Bioorg Med Chem; 2011 Jul; 19(14):4192-201. PubMed ID: 21696967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sports doping: emerging designer and therapeutic β2-agonists.
    Fragkaki AG; Georgakopoulos C; Sterk S; Nielen MW
    Clin Chim Acta; 2013 Oct; 425():242-58. PubMed ID: 23954776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.